BioLineRx Ltd., the Israeli drugmaker that last reported a profit in 2010, expects revenue from royalty payments to grow next year on prospects for drug approvals, according to Chief Executive Officer Kinneret Savitsky.
Two years before William Morris Endeavor laid off Toni Mason, the talent agency repositioned her and hired someone younger to take her old position for what Mason assumes was less pay. “They gradually made me more and more obsolete,” the 66-year-old agent says. The company was generous with its severance package when it laid her off in 2010, she says, but made her sign a waiver that she wouldn’t sue for age discrimination. The experience left her bitter. “Twenty-five years I’m at a company, at least they can give me a cake,” she says. “But I had to leave the same day.”
Reckitt Benckiser Group Plc said finance chief Liz Doherty will be replaced by a veteran of the health care industry, signaling Chief Executive Officer Rakesh Kapoor’s increasing emphasis on more profitable consumer-health and pharmaceutical products over traditional household goods.
On April 14, 2011, James Fan stood on a parking garage landing at Newark Liberty International Airport, a cheer-you-up letter from his young son in his pants pocket, the prospect of a four-story leap facing him.
UnitedHealth Group Inc., the largest U.S. provider of medical coverage, will join the Mayo Clinic in a research alliance designed to merge insurance records and medical data to find more efficient ways to deliver care.
Nuance Communications Inc., a maker of speech-recognition software, plunged the most in more than six years after the company lowered its full-year sales and earnings forecast as new technology curbed use of older transcription services.
Steven A. Cohen’s SAC Capital Advisors LP is at the center of the biggest insider case ever brought in a nationwide crackdown on illicit hedge fund trading -- one focusing on the exploitation of secret information on volatile health care stocks often obtained through expert consultants.